IDEX Biometrics ASA (OSL:IDEX) ROCE %: -755.92% (As of Mar. 2026)

What is IDEX Biometrics ASA ROCE %?

IDEX Biometrics ASA OSL:IDEX -3.86% 20 ROCE % is -755.92% as of Mar. 2026. GuruFocus rates OSL:IDEX with a GF Score™ of 20/100 and a GF Value™ of kr0.53 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IDEX Biometrics ASA's annualized ROCE % for the quarter that ended in Mar. 2026 was -755.92%.

IDEX Biometrics ASA (OSL:IDEX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IDEX Biometrics ASA ROCE % Related Terms

IDEX Biometrics ASA ROCE % Historical Data

* Premium members only.

The historical data trend for IDEX Biometrics ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEX Biometrics ASA ROCE % Chart

IDEX Biometrics ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-124.95

-107.94

-145.75

-134.24

-167.71

IDEX Biometrics ASA Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-219.61	-199.21	-69.69	-267.39	-755.92

20GF Score

IDEX Biometrics ASA OSL:IDEX

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

IDEX Biometrics ASA ROCE % Calculation

IDEX Biometrics ASA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-91.823	/	( ( (116.743 - 39.239)	+	(76.799 - 44.8) )	/ 2 )
	=	-91.823	/	( (77.504	+	31.999)	/ 2 )
	=	-91.823	/	54.7515
	=	-167.71 %

IDEX Biometrics ASA's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-98.368	/	( ( (76.799 - 44.8)	+	(75.428 - 81.401) )	/ 2 )
	=	-98.368	/	( ( 31.999	+	-5.973 )	/ 2 )
	=	-98.368	/	13.013
	=	-755.92 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -755.92% mean?

IDEX Biometrics ASA (OSL:IDEX) has a ROCE % of -755.92% as of Mar. 2026.

Is IDEX Biometrics ASA's ROCE % too high?

IDEX Biometrics ASA's current ROCE % is -755.92%. Overall, IDEX Biometrics ASA has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does IDEX Biometrics ASA's ROCE % compare to UBER and SHOP?

IDEX Biometrics ASA's ROCE % of -755.92% can be compared against companies in the Software industry. The industry median ROCE % is 5.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Software company?

The median ROCE % among Software companies is 5.19, based on 2,709 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEX Biometrics ASA's current ROCE % is -755.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is IDEX Biometrics ASA stock overvalued right now?

Based on GuruFocus' analysis, IDEX Biometrics ASA (OSL:IDEX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.53, compared to a current price of kr8.20 — trading 1447.2% above its estimated fair value. The current ROCE % is -755.92%. IDEX Biometrics ASA's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For IDEX Biometrics ASA (OSL:IDEX), the current ROCE % is -755.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEX Biometrics ASA (OSL:IDEX) Overvalued in 2026?

Based on GuruFocus' analysis, IDEX Biometrics ASA stock appears to be overvalued. The current stock price of kr8.20 is trading 1447.2% above its estimated GF Value™ of kr0.53. GuruFocus considers IDEX Biometrics ASA to be Significantly Overvalued.

Key valuation signals for OSL:IDEX:

ROCE %: -755.92%
GF Value™: kr0.53 vs. price of kr8.20 (1447.2% above fair value)
GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the OSL:IDEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEX Biometrics ASA Business Description

Industry Technology Software

Comparable Companies OSL:HUDL OSL:AIX XTER:SAP UBER SHOP CRM CDNS NOW ADP SNOW DDOG ADBE INTU TSX:CSU ADSK PAYX ROP WDAY MSTR FICO

Other Exchanges IDXAF:USA 0MTP:UK I8X:Germany

Address Henrik Ibsens gate 90, Oslo, NOR, 0255

Website https://www.idexbiometrics.com

IDEX Biometrics ASA develops and manufactures fingerprint biometric cards for access control, digital identity, and payment. Its products use fingerprint biometrics for user authentication and are designed for physical and digital access applications. The company serves banks, enterprises, and public sector organizations through direct sales and channel partners.

20GF Score

Get the complete analysis for OSL:IDEX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.20

Price

kr0.53

GF Value

View OSL:IDEX Analysis

See ROCE % data for all stocks →